Kristen Pierce insider trades
Open-market stock purchases and sales by Kristen Pierce, Chief Development Officer at Cero Therapeutics Holdings, Inc, from SEC Form 4 filings since Oct 1, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 7, 2026 | CERO Cero Therapeutics Holdings, Inc | Bought (not open market) | — |
Companies traded
- CERO Cero Therapeutics Holdings, Inc: other filings, last Jan 7, 2026